Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07012772

COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients

Led by Zhejiang University · Updated on 2025-06-24

50

Participants Needed

2

Research Sites

13 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate the use of the COMBO Endoscopy Oropharyngeal Airway device to reduce the occurrence of low oxygen levels (hypoxia) during sedation for patients undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP). The study targets patients with conditions such as choledocholithiasis with cholecystitis with obstruction, obstructive jaundice, pancreatitis, and cholelithiasis. It is conducted under phase 2 clinical trial conditions to explore this new device's role in improving patient safety during the procedure. Participants will use the COMBO Endoscopy Oropharyngeal Airway, a multifunctional device designed to provide oxygen support, protect the airways, and monitor breathing during sedated ERCP procedures. The device integrates capnography monitoring, bite block protection, oxygen delivery, and airway management tailored specifically for endoscopic procedures. This device group represents the experimental arm of the study. During the hospital stay, expected to last about 2 hours, patients will be closely monitored to measure the frequency of hypoxia, sub-clinical respiratory depression, and severe hypoxia. Researchers will observe and record these breathing-related outcomes throughout the procedure and recovery. The study includes safety evaluations and continuous monitoring to assess the device's impact on patient oxygen levels during sedation.

CONDITIONS

Brief Title

COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • ASA classification from I to III
  • Signed informed consent form
  • Scheduled to undergo sedated ERCP examination
  • Estimated procedure duration does not exceed 45 minutes
Not Eligible

You will not qualify if you...

  • Coagulation disorders or bleeding tendency making airway management unfeasible
  • Severe cardiac dysfunction with less than 4 METs
  • Severe renal insufficiency requiring preoperative dialysis
  • Child-Pugh class C liver disease
  • Chronic obstructive pulmonary disease or other pulmonary diseases requiring long-term oxygen therapy
  • Increased intracranial pressure
  • Upper respiratory tract infections
  • Fever with core temperature above 37.5°C
  • Confirmed pregnancy or current breastfeeding
  • Allergy to sedatives like propofol or medical adhesives
  • Emergency procedures
  • Multiple trauma injuries
  • Preoperative peripheral oxygen saturation below 95% on room air
  • Body mass index below 18.5 or above 30 kg/m²
  • Participation in other clinical trials
  • Other conditions deemed ineligible by investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) prior to the procedure

Implementation

Duration - Up to 45 minutes during the procedure

Participants use the COMBO Endoscopy Oropharyngeal Airway device during their sedated ERCP procedure for oxygenation.

1 visit (in-person) on the day of the procedure

Monitoring

Duration - Approximately 2 hours during hospital stay

Participants are monitored for respiratory status and oxygen levels during the hospital stay after the procedure.

Continuous monitoring during the hospital stay post-procedure

Trial Site Locations

Total: 2 locations

1

he First Affiliated Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China, 310000

Actively Recruiting

2

The First Affiliated Hospital,Zhejiang University School of Medicine

Hangzhou, Zhejiang, China, 310000

Actively Recruiting

Loading map...

Research Team

D

DiSan Head of Anesthesiology, PhD

L

Lianjuan Sun, Master

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Similar Trials

A New Strategy for Preoperative Drainage of Resectable Pancr...

Pancreatic Cancer

Actively Recruiting

1 location

Development of Biomarkers for the Early Detection, Surveilla...

Pancreatic Cancer

Actively Recruiting

13 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here